Friday February 24th 2017: Baxter International Inc., BAX is in the exchange NYSE and its industry is Medical Instruments & Supplies in the sector of Healthcare. Based in USA, Baxter International Inc., BAX has a market cap of 33.62 B. Since its IPO date on the 10/27/1981, Baxter International Inc., BAX performance year to date is 38.20%. Today Baxter International Inc., BAX has gained -0.28%, with a current price of 61.11.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 86.40%. The management of the company have seen the company have a payout ratio of 15.30%. Return of assets are at 11.80%, with return on investment at 5.30%.
In terms of debt levels and profit levels, Baxter International Inc., BAX is seeing a long-term debt/equity of 0.32. While Total debt/equity is 0.32. With a profit margin of 18.10%, this is combined with a gross margin of 38.80%, and operating margin of 20.30%. Baxter International Inc. ability to meet debt levels, with a current ratio of 2.7, while the quick ratio is 2.1.
For the last year Baxter International Inc., BAX has seen a EPS growth of 15.80%. A performance for the year of 30.80%. The 52-week high is -0.67%, and the 52-week low is 41.69%. The average volume for Baxter International Inc., BAX is 412869.
With a target price of 61.14, can Baxter International Inc., BAX reach this target? Looking at the value indicators of Baxter International Inc., BAX. Baxter International Inc. has a P/E of 18.26 and a forward P/E of 23.85. Perhaps the more useful indicator than P/E, is PEG which has a value of 1.41. Baxter International Inc. also has a P/S and a P/B of 3.28 and 3.82 respectively. For P/cash, Baxter International Inc. has a value of 11.76, while it is 27.05 for P/free cash flow.
At the current price of 61.11, Baxter International Inc. has a dividend yield of 1.04%. We see a return on equity of 21.70%.
Looking more long-term Baxter International Inc., is projected to get an EPS growth for the next five years of 12.97%. In the short-term an EPS growth of 13.22% in the next year is forecasted. This is after a EPS growth of 15.80% for this year and for the last five years a 18.40% growth has been seen.